antiviral
-
Pfizer this week revealed that it raised the list price of a course of Paxlovid — its lifesaving antiviral drug used to reduce the risk of severe COVID-19 in those most vulnerable — to nearly $1,400, more than double the roughly $530 the US government has paid for the treatment in the emergency phase of…